REBASTINIB TOSYLATE

UNII:	042A5NJE6B
Type:	INGREDIENT SUBSTANCE
Formula:	C₃₀H₂₈FN₇O₃.C₇H₈O₃S
Preferred Substance Name:	REBASTINIB TOSYLATE
InChIKey:	ARPBZBAWXAVDCE-UHFFFAOYSA-N
GSRS Full Record:	042A5NJE6B i

1033893-29-6
2-PYRIDINECARBOXAMIDE, 4-(4-((((3-(1,1-DIMETHYLETHYL)-1-(6-QUINOLINYL)-1H-PYRAZOL-5-YL)AMINO)CARBONYL)AMINO)-3-FLUOROPHENOXY)-N-METHYL-, 4-METHYLBENZENESULFONATE (1:1)
DCC-2036
DP-1919.TO
N-(3-(1,1-DIMETHYLETHYL)-1-(QUINOLIN-6-YL)-1H-PYRAZOL-5-YL)-N'-(2-FLUORO-4-((2-(METHYLCARBAMOYL)PYRIDIN-4-YL)OXY)PHENYL)UREA MONO(4-METHYLBENZENESULFONATE)
REBASTINIB TOSILATE
REBASTINIB TOSYLATE [USAN]
Rebastinib tosilate [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

REBASTINIB TOSYLATE

Synonyms and Mappings

Resources